Urgent Update: Court Ruling on Tariffs and Its Implications for Medtech
The U.S. Court of International Trade has made a landmark decision that may significantly impact medical technology companies with global supply chains. On May 28, 2025, the court struck down several Trump Executive Orders, ruling that they exceeded executive authority under the International Emergency Economic Powers Act (IEEPA). This ruling could affect tariff liabilities, supply chain planning, and duty recovery strategies for medtech companies.
Key Considerations for Medtech Companies
- Potential changes in tariff liabilities
- Impact on supply chain planning and management
- Duty recovery strategies in light of the new ruling
Expert Insights from Sally Laing
Sally Laing, Partner at Akin Gump, will provide critical insights and analysis during our emergency webinar on May 30, 2025. With 15 years of experience in international trade law and U.S. public policy, Sally will guide attendees through the implications of this decision and offer actionable advice on assessing risks and opportunities.
Webinar Details
- Date: May 30, 2025
- Time: 11:00 AM – 12:30 PM
- Location: Live Online
Who Should Attend?
- Regulatory affairs and legal counsel
- Trade compliance and logistics professionals
- Government affairs and policy teams
- Product and global market strategists
- Medtech exporters seeking tariff mitigation strategies
Registration Information
This webinar is FREE for AdvaMed® Members. Check if your company is a member here.
Register now to secure your spot and stay ahead of the curve in the ever-evolving medtech landscape.
